Vaccine and drug development

We use our extensive expertise in mucosal immunology and microbiology to develop novel vaccine and drugs that will impact patients in the UK and globally. Our translational research scope ranges from discovery science to clinical trials. We are working together with over 20 leading experts to use our unique Experimental Human Pneumococcal Carriage model to better understand host immunity and susceptibility, pneumococcal biology and as a tool of assessing vaccine efficacy.